An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021) - Lee, Shin-Wha; Kim, Yong-Man; Cho, Chi Heum; Kim, Young Tae; Kim, Seok Mo; Hur, Soo Young; Kim, Jae-Hoon; Kim, Byoung-Gie; Kim, Seung-Cheol; Ryu, Hee-Sug; Kang, Soon Beom (Cancer research and treatment, 2018)
Keywords: Antineoplastic Agents, Phytogenic - administration & dosage; Antineoplastic Agents, Phytogenic - pharmacology; Antineoplastic Agents, Phytogenic - therapeutic use; Female; Humans; Micelles; Middle Aged; Original; Ovarian Neoplasms - drug therapy; Ovarian Neoplasms - pathology; Paclitaxel - administration & dosage; Paclitaxel - pharmacology; Paclitaxel - therapeutic use; Polymers; Republic of Korea; 의약학; Carboplatin; Genexol; Genexol-PM; Ovarian neoplasms; Phase II trial